FI944933A - 7-Disubstituted methyl-4-oxo-3H, 5H-pyrrolo (3,2-d) pyrimidine and pharmaceutical uses and compositions containing it - Google Patents
7-Disubstituted methyl-4-oxo-3H, 5H-pyrrolo (3,2-d) pyrimidine and pharmaceutical uses and compositions containing it Download PDFInfo
- Publication number
- FI944933A FI944933A FI944933A FI944933A FI944933A FI 944933 A FI944933 A FI 944933A FI 944933 A FI944933 A FI 944933A FI 944933 A FI944933 A FI 944933A FI 944933 A FI944933 A FI 944933A
- Authority
- FI
- Finland
- Prior art keywords
- pyrrolo
- pyrimidine
- oxo
- compositions containing
- pharmaceutical uses
- Prior art date
Links
- RAANISQWIATQQH-UHFFFAOYSA-N 2-methyl-1,5-dihydropyrrolo[3,2-d]pyrimidin-4-one Chemical class N1C(C)=NC(=O)C2=C1C=CN2 RAANISQWIATQQH-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/35—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/40—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87144192A | 1992-04-21 | 1992-04-21 | |
PCT/US1993/002841 WO1993021187A1 (en) | 1992-04-21 | 1993-03-25 | 7-DISUBSTITUTED-METHYL-4-OXO-3H^_,5H^_-PYRROLO[3,2-d^_]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME |
Publications (2)
Publication Number | Publication Date |
---|---|
FI944933A0 FI944933A0 (en) | 1994-10-20 |
FI944933A true FI944933A (en) | 1994-10-20 |
Family
ID=25357439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI944933A FI944933A (en) | 1992-04-21 | 1994-10-20 | 7-Disubstituted methyl-4-oxo-3H, 5H-pyrrolo (3,2-d) pyrimidine and pharmaceutical uses and compositions containing it |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0638080A4 (en) |
JP (1) | JPH07507062A (en) |
KR (1) | KR950701335A (en) |
AU (1) | AU4276693A (en) |
CA (1) | CA2133346A1 (en) |
FI (1) | FI944933A (en) |
HU (1) | HUT71559A (en) |
NO (1) | NO303637B1 (en) |
RU (1) | RU94046387A (en) |
WO (1) | WO1993021187A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002500658A (en) * | 1997-05-29 | 2002-01-08 | ノバルティス アクチエンゲゼルシャフト | 2-amino-7- (1-substituted-2-hydroxyethyl) -3,5-dihydropyrrolo [3,2-d] pyrimidin-4-one |
US6355244B1 (en) | 1997-11-17 | 2002-03-12 | University Of Kentucky Research Foundation | Methods and compositions for the treatment of psoriasis |
US6174888B1 (en) | 1998-05-28 | 2001-01-16 | Novartis Ag | 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydropyrrolo[3,2-D]pyrimidin-4-ones |
GB0215392D0 (en) * | 2002-07-03 | 2002-08-14 | Glaxo Group Ltd | Chemical compounds |
US7557113B2 (en) | 2003-08-26 | 2009-07-07 | Teijin Pharma Limited | Substituted pyrrolo[3,2-d]pyrimidine derivatives |
CA2536887C (en) * | 2003-08-26 | 2012-03-06 | Teijin Pharma Limited | Pyrrolopyrimidinone derivatives |
MY140748A (en) | 2004-12-06 | 2010-01-15 | Astrazeneca Ab | Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy |
US7763257B2 (en) | 2004-12-09 | 2010-07-27 | Christina Juneau | Compositions comprising transforming growth factor (TGF)-β1 and TGF-β2 in admixture of proteins obtained from dairy products |
WO2009079797A1 (en) | 2007-12-26 | 2009-07-02 | Critical Outcome Technologies, Inc. | Compounds and method for treatment of cancer |
CA2730890C (en) | 2008-07-17 | 2018-05-15 | Critical Outcome Technologies Inc. | Thiosemicarbazone inhibitor compounds and cancer treatment methods |
CA2999435A1 (en) | 2010-04-01 | 2011-10-06 | Critical Outcome Technologies Inc. | Compounds and method for treatment of hiv |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUT61765A (en) * | 1989-10-31 | 1993-03-01 | Biocryst Inc | Process for producing purine nucleoside phosphorylase inhibitors and pharmaceutical compositions comprising same as active ingredient |
US5189039A (en) * | 1989-11-29 | 1993-02-23 | Biocryst, Inc. | 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo[3,2d]pyrimidine and pharmaceutical uses and compositions containing the same |
-
1993
- 1993-03-25 AU AU42766/93A patent/AU4276693A/en not_active Abandoned
- 1993-03-25 HU HU9403021A patent/HUT71559A/en unknown
- 1993-03-25 RU RU94046387/04A patent/RU94046387A/en unknown
- 1993-03-25 JP JP5518357A patent/JPH07507062A/en active Pending
- 1993-03-25 WO PCT/US1993/002841 patent/WO1993021187A1/en not_active Application Discontinuation
- 1993-03-25 KR KR1019940703788A patent/KR950701335A/en not_active Application Discontinuation
- 1993-03-25 EP EP93912081A patent/EP0638080A4/en not_active Withdrawn
- 1993-03-25 CA CA002133346A patent/CA2133346A1/en not_active Abandoned
-
1994
- 1994-10-20 FI FI944933A patent/FI944933A/en not_active Application Discontinuation
- 1994-10-20 NO NO943988A patent/NO303637B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
HU9403021D0 (en) | 1994-12-28 |
AU4276693A (en) | 1993-11-18 |
EP0638080A1 (en) | 1995-02-15 |
FI944933A0 (en) | 1994-10-20 |
EP0638080A4 (en) | 1995-08-23 |
WO1993021187A1 (en) | 1993-10-28 |
HUT71559A (en) | 1995-12-28 |
NO303637B1 (en) | 1998-08-10 |
NO943988D0 (en) | 1994-10-20 |
NO943988L (en) | 1994-10-20 |
CA2133346A1 (en) | 1993-10-28 |
JPH07507062A (en) | 1995-08-03 |
KR950701335A (en) | 1995-03-23 |
RU94046387A (en) | 1996-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT589843E (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORTS | |
IL106624A0 (en) | Asymmetrically substituted xanthines,their preparation and pharmaceutical compositions containing them | |
IL106431A0 (en) | Aminediol derivatives and pharmaceutical compositions containing the same | |
PH25932A (en) | Adenosine derivatives and pharmaceutical compositions containing the same | |
DE69325333D1 (en) | Antiviral composition | |
HU9802116D0 (en) | 19-nor-d-vitamin compounds with biologically effect and pharmaceutical compositions containing them | |
IL106927A0 (en) | Sulfonamide derivatives and pharmaceutical compositions containing the same | |
IL110743A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
NZ236625A (en) | Pyrimidine derivatives and pharmaceutical compositions | |
IL110988A0 (en) | 4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same | |
IL94821A0 (en) | Monosaccharide compounds and pharmaceutical compositions containing the same | |
PH27460A (en) | Pyrimidine derivatives and herbicidal composition containing the same | |
GR862456B (en) | 2-substituted-e-fused-(1,2,4) triazolo -(1,5-c)pyrimidines pharmaceutical compositions and uses thereof | |
IL105673A0 (en) | Purine derivatives and pharmaceutical compositions containing them | |
IL105672A0 (en) | Substituted adenosine derivatives and pharmaceutical compositions containing them | |
FI944933A0 (en) | 7-Disubstituted methyl-4-oxo-3H, 5H-pyrrolo (3,2-d) pyrimidine and pharmaceutical uses and compositions containing it | |
DE4294862T1 (en) | Pharmaceutical composition | |
IL108119A0 (en) | Purine derivatives their preparation and pharmaceutical compositions containing them | |
EP0587047A3 (en) | Gestagenes containing pharmaceutical composition | |
IL110509A0 (en) | Pyrimido pyrimidine compounds, their preparation and pharmaceutical compositions containing them | |
IL89376A0 (en) | Substituted pyrimidines,their preparation and pharmaceutical compositions containing them | |
IL98749A0 (en) | Pharmaceutical compositions containing penciclovir | |
HUP9903526A3 (en) | Pyrimidine derivatives and pharmaceutical compositions containing the same | |
IL89155A0 (en) | Ouabain-like compounds and pharmaceutical compositions containing them | |
IL104306A0 (en) | Nucleosides,their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |